Febuxostat: higher risk of CV-related death, all-cause mortality

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-64374-4
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [2] Febuxostat Increases All-Cause and Cardiovascular Mortality Compared with Allopurinol
    Ebel, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (06) : 385 - 385
  • [4] Social Isolation in Adults with COPD is Associated with Higher All-Cause Mortality Risk
    Suen, A.
    Kotwal, A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S5 - S6
  • [6] Healthy behaviours and risk of all-cause mortality
    Lahti, Jouni
    Mauramo, E.
    Lahelma, E.
    Lallukka, T.
    Pietilainen, O.
    Salmela, J.
    Salonsalmi, A.
    Rahkonen, O.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29
  • [7] Sitting Time and All-Cause Mortality Risk
    Peterson, Mark D.
    Sarma, Aruna V.
    Gordon, Paul M.
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (16) : 1270 - 1272
  • [8] Febuxostat Use and Risks of Cardiovascular Disease Events, Cardiac Death, and All-cause Mortality: Metaanalysis of Randomized Controlled Trials
    Deng, Hao
    Zhang, Bao Long
    Tong, Jin Dong
    Yang, Xiu Hong
    Jin, Hui Min
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1082 - 1089
  • [9] DIGOXIN USE IS ASSOCIATED WITH A HIGHER RISK OF ALL-CAUSE MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION
    Shah, M.
    Tsadok, M. Avgil
    Essebag, V.
    Jackevicius, C. A.
    Eisenberg, M. J.
    Pilote, L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S105 - S105
  • [10] Association of BMI with risk of CVD mortality and all-cause mortality
    Kee, Chee Cheong
    Sumarni, Mohd Ghazali
    Lim, Kuang Hock
    Selvarajah, Sharmini
    Haniff, Jamaiyah
    Tee, Guat Hiong Helen
    Gurpreet, Kaur
    Faudzi, Yusoff Ahmad
    Amal, Nasir Mustafa
    PUBLIC HEALTH NUTRITION, 2017, 20 (07) : 1226 - 1234